Lantheus Holdings Inc (LNTH)

Exchange
NASDAQ
Symbol
LNTH
Sector
Life Sciences
Industry
In Vitro & In Vivo Diagnostic Substances
Description
Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.
Country
USA

Stock price

At close: October 4, 2024

  • Open
    107.96
  • High
    108.63
  • Low
    105.98
  • Close
    107.79
  • Volume
    296,412

Financial ratios

Dec 31, 2023

Activity ratios
Inventory turnover
16.14
Receivables turnover
4.49
Payables turnover
25.09
Working capital turnover
1.42
Days of inventory on hand (DOH)
22.61
Days of sales outstanding (DSO)
81.30
Number of days of payables
14.55
Fixed asset turnover
8.70
Total asset turnover
0.77
 Liquidity ratios
Current ratio
5.80
Quick ratio
5.33
Cash ratio
3.81
Cash conversion cycle
89.36
 Solvency ratios
Debt-to-assets ratio
0.00
Debt-to-capital ratio
0.00
Debt-to-equity ratio
0.00
Financial leverage ratio
2.02
Interest coverage
21.53
 Profitability ratios
Gross profit margin
55.59%
Operating profit margin
28.57%
Pretax margin
32.20%
Net profit margin
25.59%
Operating return on assets (Operating ROA)
22.08%
Return on assets (ROA)
19.78%
Return on total capital
52.82%
Return on equity (ROE)
40.04%